Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Blake

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|February 22, 2020
Please consider my science-fiction storyDavid G Blake
Nature|September 2, 2021
Some dogs kick when they dreamDavid G Blake
Journal of Cutaneous Pathology|November 22, 2012
Langerhans cell histiocytosis associated with lichen sclerosus of the vulva: case report and review of the literatureJason C Chang, David G Blake, Belinda V Leung, et al.
Cell Chemical Biology|July 19, 2018
The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1Russell J Pearson, David G Blake, Mokdad Mezna, et al.
Evolution, Medicine, and Public Health|October 10, 2025
Dual targeting of conserved cell cycle and transcription programs in advanced colorectal cancer by fadraciclibMohammad Zokaasadi, Wylie K Watlington, Divya L Dayanidhi, et al.
Plos Neglected Tropical Diseases|April 13, 2011
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinaseRoderick G Walker, Graeme Thomson, Kirk Malone, et al.
Journal of Medicinal Chemistry|February 12, 2010
Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitorsNeil A McIntyre, Campbell McInnes, Gary Griffiths, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|February 22, 2020
Please consider my science-fiction storyDavid G Blake
Nature|September 2, 2021
Some dogs kick when they dreamDavid G Blake
Journal of Cutaneous Pathology|November 22, 2012
Langerhans cell histiocytosis associated with lichen sclerosus of the vulva: case report and review of the literatureJason C Chang, David G Blake, Belinda V Leung, et al.
Cell Chemical Biology|July 19, 2018
The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1Russell J Pearson, David G Blake, Mokdad Mezna, et al.
Evolution, Medicine, and Public Health|October 10, 2025
Dual targeting of conserved cell cycle and transcription programs in advanced colorectal cancer by fadraciclibMohammad Zokaasadi, Wylie K Watlington, Divya L Dayanidhi, et al.
Plos Neglected Tropical Diseases|April 13, 2011
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinaseRoderick G Walker, Graeme Thomson, Kirk Malone, et al.
Journal of Medicinal Chemistry|February 12, 2010
Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitorsNeil A McIntyre, Campbell McInnes, Gary Griffiths, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Pageof 1